If you hadn’t heard about messenger RNA before early 2020, with the advent of mRNA-based Covid-19 vaccines you almost certainly have by now. Billions of doses of the vaccines have been delivered worldwide. But researchers, observers, and biotech bigwigs are betting that the potential for mRNA to transform the drug industry extends well beyond its usefulness in infectious disease immunization.

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Boost HIPAA Compliance with CyberArk Privileged Access Management Solutions
Next post Medtech Dive Outlook for 2023